Nuveen Asset Management, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,922,111
-32.0%
603,497
+50.0%
0.00%
-50.0%
Q2 2023$10,184,592
+78496.9%
402,394
+0.0%
0.00%
-20.0%
Q1 2023$12,958
+40.2%
402,282
-19.7%
0.01%
+25.0%
Q4 2022$9,245
-99.9%
500,847
-19.1%
0.00%
-42.9%
Q3 2022$16,717,000
+236.8%
619,164
+72.4%
0.01%
+250.0%
Q2 2022$4,963,000
-29.8%
359,120
-3.2%
0.00%0.0%
Q1 2022$7,068,000
+15.9%
370,821
-0.8%
0.00%0.0%
Q4 2021$6,100,000
-43.1%
373,732
-2.8%
0.00%
-33.3%
Q3 2021$10,717,000
-35.6%
384,664
-31.4%
0.00%
-40.0%
Q2 2021$16,631,000
+30.4%
561,094
+23.0%
0.01%
+25.0%
Q1 2021$12,754,000
-5.5%
456,323
-4.2%
0.00%
-20.0%
Q4 2020$13,494,000
+26.0%
476,149
+11.8%
0.01%
+25.0%
Q3 2020$10,710,000
+9.4%
426,021
+6.3%
0.00%0.0%
Q2 2020$9,789,000
+88.3%
400,856
+14.1%
0.00%
+33.3%
Q1 2020$5,199,000
-2.0%
351,250
+7.5%
0.00%
+50.0%
Q4 2019$5,303,000
+32.7%
326,716
+6.3%
0.00%0.0%
Q3 2019$3,996,000
+51.5%
307,372
+51.2%
0.00%
+100.0%
Q2 2019$2,638,000203,3370.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$48,000,00065.50%
Essex Woodlands Management, Inc. 3,842,047$118,335,00025.90%
Rhenman & Partners Asset Management AB 203,181$6,258,0000.77%
EAM Global Investors LLC 44,898$1,383,0000.72%
Fosun International Ltd 319,313$9,835,0000.62%
EAM Investors, LLC 113,096$3,483,0000.58%
ArrowMark Colorado Holdings LLC 1,735,699$53,460,0000.53%
Perceptive Advisors 618,957$19,064,0000.53%
ESSEX INVESTMENT MANAGEMENT CO LLC 111,360$3,430,0000.45%
Schonfeld Strategic Advisors LLC 83,700$2,578,0000.19%
View complete list of REVANCE THERAPEUTICS INC shareholders